New York City-based Memorial Sloan Kettering Cancer Center reported operating income of $216.6 million (4.7% operating margin), up from an operating loss of $113.2 million (-2.7% margin) during the same period last year, according to its Aug. 14 financial report.
Memorial Sloan Kettering said its operating performance was driven by increased patient throughput, improved patient access and continued management of operating costs. The cancer center said it also realized operational efficiencies from its Epic EHR, which was implemented in February 2025. MSK incurred $140.9 million in incremental expenses associated with the Epic go-live in 2025.
MSK reported total operating revenue of $4.6 billion for the six months ended June 30, up from $4.1 billion during the same period last year. Hospital care and services totaled $3.9 billion, up from $3.4 billion. Grants and contracts totaled $268.5 million, down from $281.5 million. Other income totaled $149.5 million, up from $88.3 million. The 2026 other income figure included $56.6 million in COVID-19 relief funding and $8.2 million in payer settlement payments
Total operating expenses were $4.4 billion, up from $4.2 billion. Compensation and fringe benefits remained relatively flat at $2.1 billion. Purchased supplies and services totaled $1.9 billion, up from $1.8 billion.
MSK reported a net income of $780 million in the first half of 2026, up from $59 million during the same period last year.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
